Bank of Montreal’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Bank of Montreal’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-836	Closed	-$4K	–	4358
2017 Q1	$4K	Hold	836	–	–	﹤0.01%	3748
2016 Q4	$8K	Hold	836	–	–	﹤0.01%	3665
2016 Q3	$8K	Hold	836	–	–	﹤0.01%	3617
2016 Q2	$5K	Hold	836	–	–	﹤0.01%	3754
2016 Q1	$5K	Buy	+836	New	+$5.39K	﹤0.01%	3811

Other funds holding FOMX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of Montreal's FOMX Position: Q2 2017 in Review

Bank of Montreal sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2017, closing a stake of 836 shares — an estimated $4K sold.

Bank of Montreal first reported a position in FOMX in Q1 2016 and held it in 5 quarters. The position peaked at $8K in Q4 2016. 56 funds tracked by Wall St. Rank hold FOMX as of Q2 2017.

Bank of Montreal reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2017 after selling out during the quarter.
Bank of Montreal sold 836 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2017, an estimated $4K.
Bank of Montreal first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2016 and held it in 5 quarters.
Bank of Montreal's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $8K in Q4 2016.
56 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2017.

Based on Bank of Montreal's 13F filing for Q2 2017, filed 11 Jul 2017.